next generation SQZ APC (SQZ Biotech/Roche)

N/A

Report date: 2025/03/20 15:11:54

Base Information

Drug Namenext generation SQZ APC (SQZ Biotech/Roche)
Drug Alias NameN/A
ClassificationCell and gene therapy > Cell therapy > Immune system cell therapy
Mechanisms of ActionT lymphocytes stimulantsImmunostimulants
TargetsUpdating
Therapy Area/IndicationsSolid tumoursHematologic Neoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesSqz Biotechnologies Company
China Registration ClassN/A

Develop Information

Active CompaniesRoche Holding LtdSqz Biotechnologies Company
Inactive CompaniesN/A
Active IndicationsSolid tumoursHematologic Neoplasms
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A